Adequan Again Shipping Product, Supplies Limited
8 years ago StraightArrow Comments Off on Adequan Again Shipping Product, Supplies Limited
SHIRLEY, New York, Sept. 17–A shipment of Adequan (polysulfated glycosaminoglycan) IM produced at its upgraded manufacturing plant, has been shipped to veterinarians.
Luitpold Animal Health, a division of Luitpold Pharmaceuticals, Inc. that manufactures Adequan, said the product remains limited and initial shipments will not fully satisfy market demand.
Luitpold manufactures Adequan IM, Adequan IA, and Adequan Canine.
The company made significant investment in upgrading manufacturing facilities earlier this year that interrupted supplies of the product.
“We are working diligently to release additional product to the market and will provide updates as they become available,” said Allyn Mann, Director of Luitpold Animal Health. “Quality and integrity remain our highest priorities.”
Adequan IM and IA are the only polysulfated glycosaminoglycan approved by the U.S. Food and Drug Administration for treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness in horses. Adequan® Canine is the only polysulfated glycosaminoglycan approved by the FDA for control of signs associated with non-infectious degenerative and/or traumatic arthritis of canine synovial joints.